184 related articles for article (PubMed ID: 36867377)
1. Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment.
Clasen SC; Fung C; Sesso HD; Travis LB
Curr Oncol Rep; 2023 May; 25(5):445-454. PubMed ID: 36867377
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life.
Lubberts S; Groot HJ; de Wit R; Mulder S; Witjes JA; Kerst JM; Groenewegen G; Lefrandt JD; van Leeuwen FE; Nuver J; Schaapveld M; Gietema JA
J Clin Oncol; 2023 Jul; 41(19):3512-3522. PubMed ID: 37071834
[TBL] [Abstract][Full Text] [Related]
3. Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
Abu Zaid M; Dinh PC; Monahan PO; Fung C; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Sesso HD; Huddart R; Mushiroda T; Kubo M; Dolan ME; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2019 May; 17(5):459-468. PubMed ID: 31085753
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.
Willemse PM; Burggraaf J; Hamdy NA; Weijl NI; Vossen CY; van Wulften L; van Steijn-van Tol AQ; Rosendaal FR; Osanto S
Br J Cancer; 2013 Jul; 109(1):60-7. PubMed ID: 23660945
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.
Zaid MA; Gathirua-Mwangi WG; Fung C; Monahan PO; El-Charif O; Williams AM; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse SK; Ardeshir-Rouhani-Fard S; Dinh PC; Sesso HD; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2018 Mar; 16(3):257-265. PubMed ID: 29523664
[No Abstract] [Full Text] [Related]
6. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer.
Lauritsen J; Hansen MK; Bandak M; Kreiberg MB; Skøtt JW; Wagner T; Gundgaard Kier MG; Holm NV; Agerbæk M; Gupta R; Dehlendorff C; Andersen KK; Daugaard G
J Clin Oncol; 2020 Feb; 38(6):584-592. PubMed ID: 31821065
[TBL] [Abstract][Full Text] [Related]
9. Shared-care survivorship program for testicular cancer patients: safe and feasible.
Boer H; Lubberts S; Bunskoek S; Nuver J; Lefrandt JD; Steursma G; Sluiter WJ; Siesling S; Berendsen AJ; Gietema JA
ESMO Open; 2022 Jun; 7(3):100488. PubMed ID: 35576694
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
11. Hypogonadism in testicular cancer patients is associated with risk factors of cardiovascular disease and the metabolic syndrome.
Bogefors C; Isaksson S; Bobjer J; Kitlinski M; Leijonhufvud I; Link K; Giwercman A
Andrology; 2017 Jul; 5(4):711-717. PubMed ID: 28544654
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome.
Bucher-Johannessen C; Page CM; Haugen TB; Wojewodzic MW; Fosså SD; Grotmol T; Haugnes HS; Rounge TB
Clin Epigenetics; 2019 Dec; 11(1):179. PubMed ID: 31796056
[TBL] [Abstract][Full Text] [Related]
13. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
14. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial.
Adams SC; DeLorey DS; Davenport MH; Stickland MK; Fairey AS; North S; Szczotka A; Courneya KS
Cancer; 2017 Oct; 123(20):4057-4065. PubMed ID: 28708930
[TBL] [Abstract][Full Text] [Related]
15. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia and cardiovascular disease risk among the MASHAD study population.
Hedayatnia M; Asadi Z; Zare-Feyzabadi R; Yaghooti-Khorasani M; Ghazizadeh H; Ghaffarian-Zirak R; Nosrati-Tirkani A; Mohammadi-Bajgiran M; Rohban M; Sadabadi F; Rahimi HR; Ghalandari M; Ghaffari MS; Yousefi A; Pouresmaeili E; Besharatlou MR; Moohebati M; Ferns GA; Esmaily H; Ghayour-Mobarhan M
Lipids Health Dis; 2020 Mar; 19(1):42. PubMed ID: 32178672
[TBL] [Abstract][Full Text] [Related]
17. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
Carrington MJ; Zimmet P
BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.
Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
Front Immunol; 2022; 13():1077166. PubMed ID: 36700208
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk in long-term survivors of testicular cancer.
Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
[TBL] [Abstract][Full Text] [Related]
20. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
